215 related articles for article (PubMed ID: 28977806)
1. Influenza vaccine for 2017-2018.
Med Lett Drugs Ther; 2017 Oct; 59(1531):163-166. PubMed ID: 28977806
[No Abstract] [Full Text] [Related]
2. Influenza vaccine for 2018-2019.
Med Lett Drugs Ther; 2018 Oct; 60(1558):169-173. PubMed ID: 30335044
[No Abstract] [Full Text] [Related]
3. Does Vitamin D Deficiency Affect the Immunogenic Responses to Influenza Vaccination? A Systematic Review and Meta-Analysis.
Lee MD; Lin CH; Lei WT; Chang HY; Lee HC; Yeung CY; Chiu NC; Chi H; Liu JM; Hsu RJ; Cheng YJ; Yeh TL; Lin CY
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29587438
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
[No Abstract] [Full Text] [Related]
5. Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season.
Wkly Epidemiol Rec; 2017 Oct; 92(42):625-33. PubMed ID: 29052409
[No Abstract] [Full Text] [Related]
6. Influenza vaccine for 2016-2017.
Med Lett Drugs Ther; 2016 Oct; 58(1505):127-130. PubMed ID: 27701363
[No Abstract] [Full Text] [Related]
7. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
8. Response to influenza vaccine in people with non-protective HI antibody titers.
Baldo V; Baldovin T; Floreani A; Minuzzo M; Trivello R
Eur J Epidemiol; 2006; 21(11):843-5. PubMed ID: 17082899
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Kidney Transplant Recipients.
Kumar D; Campbell P; Hoschler K; Hidalgo L; Al-Dabbagh M; Wilson L; Humar A
Transplantation; 2016 Mar; 100(3):662-9. PubMed ID: 26335915
[TBL] [Abstract][Full Text] [Related]
10. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
[TBL] [Abstract][Full Text] [Related]
11. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
Nunzi E; Iorio AM; Camilloni B
Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine for 2020-2021.
Med Lett Drugs Ther; 2020 Sep; 62(1607):145-150. PubMed ID: 32960868
[No Abstract] [Full Text] [Related]
13. Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older.
Greenberg DP; Robertson CA; Talbot HK; Decker MD
Hum Vaccin Immunother; 2017 Sep; 13(9):2058-2064. PubMed ID: 28700265
[TBL] [Abstract][Full Text] [Related]
14. The influenza universe in an mRNA vaccine.
Kelvin AA; Falzarano D
Science; 2022 Nov; 378(6622):827-828. PubMed ID: 36423290
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of vaccination against seasonal 2012 influenza virus among patients with psoriatic arthritis and psoriasis.
Polachek A; Korobko U; Mader-Balakirski N; Arad U; Levartovsky D; Kaufman I; Anouk M; Litinsky I; Wigler I; Mendelson E; Paran D; Matz H; Caspi D; Mandelboim M; Elkayam O
Clin Exp Rheumatol; 2015; 33(2):181-6. PubMed ID: 25738420
[TBL] [Abstract][Full Text] [Related]
16. [Do you have a grip on influenza? (interview by Dr. Thomas Meissner)].
Heilbronn R
MMW Fortschr Med; 2007 Mar; 149(9):16. PubMed ID: 17615653
[No Abstract] [Full Text] [Related]
17. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A
Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
[TBL] [Abstract][Full Text] [Related]
19. [Hopeful vaccines: influenza and tuberculosis in reverse].
Nau JY
Rev Med Suisse; 2013 Feb; 9(373):386-7. PubMed ID: 23477075
[No Abstract] [Full Text] [Related]
20. Quadrivalent inactivated influenza vaccine (VaxigripTetra™).
Gresset-Bourgeois V; Leventhal PS; Pepin S; Hollingsworth R; Kazek-Duret MP; De Bruijn I; Samson SI
Expert Rev Vaccines; 2018 Jan; 17(1):1-11. PubMed ID: 29157068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
